NPI: 1174043046 · GLENDALE, CA 91201 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 06/22/2017
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 06/22/2017 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2019 | 1,111 | $51K |
| 2020 | 3,580 | $172K |
| 2021 | 15,513 | $536K |
| 2022 | 16,228 | $861K |
| 2023 | 21,219 | $1.20M |
| 2024 | 18,517 | $665K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 40,605 | 3,279 | $2.59M |
| 0821 | 637 | 233 | $630K | |
| 90945 | 5,741 | 240 | $185K | |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 9,756 | 1,293 | $32K |
| A4657 | Syringe, with or without needle, each | 2,874 | 1,334 | $20K |
| J1756 | Injection, iron sucrose, 1 mg | 5,089 | 1,544 | $11K |
| 0250 | 2,519 | 231 | $6K | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 758 | 477 | $4K |
| 83970 | 911 | 872 | $3K | |
| J1270 | Injection, doxercalciferol, 1 mcg | 2,149 | 239 | $2K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 164 | 158 | $1K |
| 82728 | 827 | 789 | $1K | |
| 90662 | 36 | 36 | $331.43 | |
| 85041 | 1,147 | 1,106 | $281.61 | |
| 83540 | 842 | 792 | $271.89 | |
| 83550 | 577 | 544 | $232.43 | |
| 85048 | 1,067 | 1,021 | $116.20 | |
| 0302 | 345 | 267 | $88.03 | |
| 90674 | 13 | 13 | $47.13 | |
| G0008 | Administration of influenza virus vaccine | 16 | 16 | $31.37 |
| 85045 | 31 | 24 | $0.00 | |
| 82108 | 48 | 46 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 16 | 13 | $0.00 |